English
Satralizumab Biosimilar - Research Grade
Satralizumab Biosimilar - Research Grade, Human IgG2(C131S/R133K/E137G/C219S/H264Q/R351Q/S374A/Q415E/N430A)-Kappa
Artikelnummer
ICH5106-50MG
Verpackungseinheit
50mg
Hersteller
Ichorbio
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Target: IL-6R.
Specificity: Detects human IL-6R.
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background: Uses the same sequence as the therapeutic antibody Satralizumab.
Concentration: 5mg/ml.
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.
Endotoxin: <1EU/mg Determined by LAL gel clotting assay.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Specificity: Detects human IL-6R.
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background: Uses the same sequence as the therapeutic antibody Satralizumab.
Concentration: 5mg/ml.
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.
Endotoxin: <1EU/mg Determined by LAL gel clotting assay.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
| Artikelnummer | ICH5106-50MG |
|---|---|
| Hersteller | Ichorbio |
| Hersteller Artikelnummer | ICH5106-50MG |
| Verpackungseinheit | 50mg |
| Mengeneinheit | STK |
| Reaktivität | Human |
| Klonalität | Monoclonal |
| Methode | Functional Assay |
| Isotyp | Human IgG2(C131S/R133K/E137G/C219S/H264Q/R351Q/S374A/Q415E/N430A)-Kappa |
| Produktinformation (PDF) | Download |
| MSDS (PDF) | Download |
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
